Noonberg Sarah B. Insider Trades

Insider Trading History

Track insider trading activity for Noonberg Sarah B.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Neurogene
Neurogene NGNE
Director
Holding Value $372k 12,050 shares
Last Trade
Feb 20, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$213k 12,050 shares
$17.64
$30.86
Neurogene
Neurogene NGNE
Director
Holding Value $372k 12,050 shares
Last Trade
Jun 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$246k 12,050 shares
$20.40
$30.86
Metagenomi
Metagenomi MGX
Chief Medical Officer
Holding Value $135k 109,135 shares
Last Trade
Jun 06, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$9.17k 5,239 shares
$1.75
$1.24
Metagenomi
Metagenomi MGX
Chief Medical Officer
Holding Value $142k 114,374 shares
Last Trade
Apr 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$111k 84,000 shares
$1.32
$1.24
Marinus Pharmaceuticals
Marinus Pharmaceuticals MRNS
Director
Holding Value $7.76k 14,100 shares
Last Trade
Jun 18, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$14.6k 10,450 shares
$1.40
$0.55
Neurogene
Neurogene NGNE
Director
Holding Value $238k 7,700 shares
Last Trade
Jun 14, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$328k 7,700 shares
$42.59
$30.86
Marinus Pharmaceuticals
Marinus Pharmaceuticals MRNS
Director
Holding Value $11.5k 20,900 shares
Last Trade
Jan 18, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$204k 20,900 shares
$9.74
$0.55
Neoleukin Therapeutics
Neoleukin Therapeutics NLTX
Director
Holding Value $53.7k 15,400 shares
Last Trade
Jan 16, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$53.7k 15,400 shares
$3.49
$3.49
Neoleukin Therapeutics
Neoleukin Therapeutics NLTX
Director
Holding Value $87.3k 25,000 shares
Last Trade
Jun 08, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$3.49
Neurogene
Neurogene NGNE
Director
Holding Value $772k 25,000 shares
Last Trade
Jun 08, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$395k 25,000 shares
$15.80
$30.86
Marinus Pharmaceuticals
Marinus Pharmaceuticals MRNS
Director
Holding Value $17.8k 32,400 shares
Last Trade
May 16, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$276k 32,400 shares
$8.51
$0.55
Protagonist Therapeutics
Protagonist Therapeutics PTGX
Director
Holding Value $3.57M 30,000 shares
Last Trade
Jan 16, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$365k 30,000 shares
$12.17
$118.96
Protagonist Therapeutics
Protagonist Therapeutics PTGX
Director
Holding Value $2.38M 20,000 shares
Last Trade
May 26, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$166k 20,000 shares
$8.31
$118.96
Neoleukin Therapeutics
Neoleukin Therapeutics NLTX
Director
Holding Value $87.3k 25,000 shares
Last Trade
May 12, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$3.49
Protagonist Therapeutics
Protagonist Therapeutics PTGX
Director
Holding Value $2.14M 18,000 shares
Last Trade
May 27, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$634k 18,000 shares
$35.23
$118.96
Neoleukin Therapeutics
Neoleukin Therapeutics NLTX
Director
Holding Value $87.3k 25,000 shares
Last Trade
May 11, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$3.49
Protagonist Therapeutics
Protagonist Therapeutics PTGX
Director
Holding Value $440k 3,700 shares
Last Trade
Feb 11, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$92.8k 3,700 shares
$25.09
$118.96
Protagonist Therapeutics
Protagonist Therapeutics PTGX
Director
Holding Value $428k 3,600 shares
Last Trade
Feb 11, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$92.8k 3,700 shares
$25.09
$118.96
Protagonist Therapeutics
Protagonist Therapeutics PTGX
Director
Holding Value $0 0 shares
Last Trade
Feb 11, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$92.8k 3,700 shares
$25.09
$118.96
Protagonist Therapeutics
Protagonist Therapeutics PTGX
Director
Holding Value $47.6k 400 shares
Last Trade
Feb 10, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$120k 4,700 shares
$25.47
$118.96

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up